Minireviews
Copyright ©The Author(s) 2016.
World J Transplant. Mar 24, 2016; 6(1): 144-154
Published online Mar 24, 2016. doi: 10.5500/wjt.v6.i1.144
Table 1 Comparison of pk parameters of tacrolimus administered as extended release tacrolimus and tacrolimus-BID[12]
Day 1
Day 14
Week 6
PK parameterExtended release tacrolimus (n = 34)Tacrolimus-BID (n = 32)Extended release tacrolimus (n = 34)Tacrolimus-BID (n = 32)Extended release tacrolimus (n = 34)Tacrolimus-BID (n = 32)
Mean (SD)
AUC0-24 (ng・h/mL)231.91 (102.33)361.49 (214.65)363.93 (96.61)343.69 (105.83)331.49 (86.82)382.60 (171.22)
Cmax (ng/mL)18.24 (7.63)34.16 (13.86)29.87 (9.61)31.74 (12.62)26.38 (7.30)33.04 (13.04)
Cmin (ng/mL)8.25 (5.01)10.12 (6.98)9.64 (3.25)10.02 (3.04)9.60 (2.93)12.06 (5.91)
Tmax (h)4.4 (4.3)1.7 (1.0)2.4 (1.2)1.6 (0.9)2.4 (1.3)1.9 (1.3)
Mean daily dose (mg/kg)0.1890.1850.2030.190.1750.164
Table 2 Equivalence comparison of pharmacokinetic parameters after conversion tacrolimus-BID to extended release tacrolimus[19]
PK parameterExtended release tacrolimus (n = 60)Tacrolimus-BID (n = 60)Ratio (90%CI) extended release tacrolimus: Tacrolimus-BID
AUC0-24 (ng・h/mL)217.75234.4292.9% (89.9-96.0)
Cmax (ng/mL)15.9921.8473.2% (67.7-78.7)
Cmin (ng/mL)6.607.2690.9% (87.3-94.6)